{"transactions":[{"id":919016,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-04T21:10:05.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 2, 2026 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2026, subject to the reporting person's continued service on each such vesting date."}],"balance_after":170000,"derivative":{"exercise_price":10.72,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001193125-26-037576","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526037576/ownership.xml","form_type":"4"}},{"id":964221,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-12-17T21:10:03.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":3452,"price":12.92,"value":44599.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,252 shares that were previously acquired under the Issuer's employee stock purchase plan."}],"balance_after":10252,"source":{"system":"sec-edgar","filing":"0001193125-25-322740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000119312525322740/ownership.xml","form_type":"4"}},{"id":1292780,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-28T21:15:06.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 24, 2025 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2025, subject to the reporting person's continued service on each such vesting date."}],"balance_after":225000,"derivative":{"exercise_price":4.16,"expiration_date":"2035-01-24","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000950170-25-009813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017025009813/ownership.xml","form_type":"4"}},{"id":1399358,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2024-09-25T20:55:56.000Z","date":"2024-09-23","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in accordance with the following schedule: (i) one-third of the shares subject to the option vest on January 1, 2025; (ii) one-third of the shares subject to the option vest on January 1, 2026; and (iii) one-third of the shares subject to the option vest on January 1, 2027."}],"balance_after":30000,"derivative":{"exercise_price":2.46,"expiration_date":"2034-09-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-24-102837","document":"tm2424771-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465924102837/tm2424771-5_4seq1.xml","form_type":"4"}},{"id":1666243,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-31T02:00:05.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 26, 2024 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2024, subject to the reporting person's continued service on each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":6.95,"expiration_date":"2034-01-25","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-24-009092","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017024009092/ownership.xml","form_type":"4"}},{"id":1835103,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2023-07-05T20:07:52.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in accordance with the following schedule: (i) one-third of the shares subject to the option vest on January 1, 2024; (ii) one-third of the shares subject to the option vest on January 1, 2025; and (iii) one-third of the shares subject to the option vest on January 1, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."}],"balance_after":100000,"derivative":{"exercise_price":1.14,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-23-078090","document":"tm2320488-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465923078090/tm2320488-2_4seq1.xml","form_type":"4"}},{"id":1911136,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-28T20:16:04.000Z","date":"2023-04-26","kind":"grant","planned":false,"acquired":true,"shares":127500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options were granted to the reporting person under the Fulcrum 2019 Stock Incentive Plan (the \"Plan\") as part of an executive retention program and will vest 25% on the first anniversary of the grant date. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years, such that the options will be vested in full on the four-year anniversary of the grant date, and subject to the reporting person's continuing to be an \"Eligible Participant\" (as defined in the Plan) on each such vesting date."}],"balance_after":127500,"derivative":{"exercise_price":2.58,"expiration_date":"2033-04-25","underlying":"Common Stock","underlying_shares":127500},"source":{"system":"sec-edgar","filing":"0000950170-23-015824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000095017023015824/ownership.xml","form_type":"4"}},{"id":2019359,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-13T21:15:31.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 9, 2023 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2023, subject to the reporting person's continued service on each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":12.59,"expiration_date":"2033-02-08","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-23-004745","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924323004745/doc4.xml","form_type":"4"}},{"id":2187770,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-11T20:15:30.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 9, 2022 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of August 9, 2022. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service"}],"balance_after":50000,"derivative":{"exercise_price":7.4,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-22-028368","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924322028368/doc4.xml","form_type":"4"}},{"id":2428498,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T21:15:12.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 19, 2022 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2022, subject to continued service."}],"balance_after":60000,"derivative":{"exercise_price":12.69,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-22-002877","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924322002877/doc4.xml","form_type":"4"}},{"id":2439644,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-01-07T21:15:16.000Z","date":"2021-12-17","kind":"gift","acquired":false,"shares":1088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Consists of 1,248 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan on November 12, 2021."}],"balance_after":1248,"source":{"system":"sec-edgar","filing":"0000899243-22-001356","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924322001356/doc5.xml","form_type":"5"}},{"id":2461990,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-21T21:24:57.000Z","date":"2021-12-17","kind":"grant","acquired":true,"shares":49020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock award (RSA) vests on December 17, 2024, three years after the date granted."}],"balance_after":49020,"source":{"system":"sec-edgar","filing":"0001104659-21-152195","document":"tm2135922-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465921152195/tm2135922-5_4seq1.xml","form_type":"4"}},{"id":2651107,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-06-29T20:16:09.000Z","date":"2021-06-28","kind":"purchase","acquired":true,"shares":1088,"price":9.01,"value":9802.88,"ownership":{"direct":true},"balance_after":1088,"source":{"system":"sec-edgar","filing":"0000899243-21-026556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924321026556/doc4.xml","form_type":"4"}},{"id":2954790,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-07T21:30:07.000Z","date":"2020-12-03","kind":"grant","acquired":true,"shares":153600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 3, 2020 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of November 30, 2020. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service."}],"balance_after":153600,"derivative":{"exercise_price":11.82,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":153600},"source":{"system":"sec-edgar","filing":"0000899243-20-032867","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680581/000089924320032867/doc4.xml","form_type":"4"}},{"id":3670711,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-07T16:30:49.000Z","date":"2019-02-05","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning August 15, 2018."}],"balance_after":363900,"derivative":{"exercise_price":8.94,"expiration_date":"2027-08-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001562180-19-000816","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000816/primarydocument.xml","form_type":"4"}},{"id":3670710,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-02-07T16:30:49.000Z","date":"2019-02-05","kind":"sale","acquired":false,"shares":40000,"price":20,"value":800000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":15021,"source":{"system":"sec-edgar","filing":"0001562180-19-000816","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000816/primarydocument.xml","form_type":"4"}},{"id":3670709,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-02-07T16:30:49.000Z","date":"2019-02-05","kind":"exercise","acquired":true,"shares":40000,"price":8.94,"value":357600.0,"ownership":{"direct":true},"balance_after":55021,"source":{"system":"sec-edgar","filing":"0001562180-19-000816","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000816/primarydocument.xml","form_type":"4"}},{"id":3670708,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-02-07T16:30:49.000Z","date":"2019-01-29","kind":"exercise","acquired":true,"shares":11100,"price":8.94,"value":99234.0,"ownership":{"direct":true},"balance_after":15021,"source":{"system":"sec-edgar","filing":"0001562180-19-000816","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000816/primarydocument.xml","form_type":"4"}},{"id":3684031,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-29T16:27:01.000Z","date":"2019-01-29","kind":"exercise","acquired":false,"shares":11100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal annual installments beginning August 15, 2018."}],"balance_after":403900,"derivative":{"exercise_price":8.94,"expiration_date":"2027-08-15","underlying":"Common Stock","underlying_shares":11100},"source":{"system":"sec-edgar","filing":"0001562180-19-000564","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000564/primarydocument.xml","form_type":"4"}},{"id":3684030,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-29T16:27:01.000Z","date":"2019-01-25","kind":"exercise","acquired":false,"shares":14029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal annual installments beginning August 15, 2018."}],"balance_after":415000,"derivative":{"exercise_price":8.94,"expiration_date":"2027-08-15","underlying":"Common Stock","underlying_shares":14029},"source":{"system":"sec-edgar","filing":"0001562180-19-000564","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000564/primarydocument.xml","form_type":"4"}},{"id":3684029,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-01-29T16:27:01.000Z","date":"2019-01-25","kind":"sale","acquired":false,"shares":14029,"price":18.0001,"value":252523.4029,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $18.00 to $18.001. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":3921,"source":{"system":"sec-edgar","filing":"0001562180-19-000564","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000564/primarydocument.xml","form_type":"4"}},{"id":3684028,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-01-29T16:27:01.000Z","date":"2019-01-25","kind":"exercise","acquired":true,"shares":14029,"price":8.94,"value":125419.26,"ownership":{"direct":true},"balance_after":17950,"source":{"system":"sec-edgar","filing":"0001562180-19-000564","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000564/primarydocument.xml","form_type":"4"}},{"id":3689647,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-23T16:47:06.000Z","date":"2019-01-18","kind":"exercise","acquired":false,"shares":1251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning August 15, 2018."}],"balance_after":429029,"derivative":{"exercise_price":8.94,"expiration_date":"2027-08-15","underlying":"Common Stock","underlying_shares":1251},"source":{"system":"sec-edgar","filing":"0001562180-19-000430","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000430/primarydocument.xml","form_type":"4"}},{"id":3689646,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-01-23T16:47:06.000Z","date":"2019-01-18","kind":"sale","acquired":false,"shares":1251,"price":18,"value":22518.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3921,"source":{"system":"sec-edgar","filing":"0001562180-19-000430","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000430/primarydocument.xml","form_type":"4"}},{"id":3689645,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-01-23T16:47:06.000Z","date":"2019-01-18","kind":"exercise","acquired":true,"shares":1251,"price":8.94,"value":11183.94,"ownership":{"direct":true},"balance_after":5172,"source":{"system":"sec-edgar","filing":"0001562180-19-000430","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000430/primarydocument.xml","form_type":"4"}},{"id":3693462,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-17T16:58:19.000Z","date":"2019-01-15","kind":"exercise","acquired":false,"shares":19720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal annual installments beginning August 15, 2018."}],"balance_after":430280,"derivative":{"exercise_price":8.94,"expiration_date":"2027-08-15","underlying":"Common Stock","underlying_shares":19720},"source":{"system":"sec-edgar","filing":"0001562180-19-000338","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000338/primarydocument.xml","form_type":"4"}},{"id":3693461,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-01-17T16:58:19.000Z","date":"2019-01-15","kind":"sale","acquired":false,"shares":19720,"price":18.0598,"value":356139.256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $18.00 to $18.17. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":3921,"source":{"system":"sec-edgar","filing":"0001562180-19-000338","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000338/primarydocument.xml","form_type":"4"}},{"id":3693460,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2019-01-17T16:58:19.000Z","date":"2019-01-15","kind":"exercise","acquired":true,"shares":19720,"price":8.94,"value":176296.8,"ownership":{"direct":true},"balance_after":23641,"source":{"system":"sec-edgar","filing":"0001562180-19-000338","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000338/primarydocument.xml","form_type":"4"}},{"id":3727431,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2018-12-18T19:48:42.000Z","date":"2018-12-16","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested and were settled in common stock on December 16, 2018."}],"balance_after":21000,"derivative":{"exercise_price":0,"expiration_date":"2021-12-17","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001562180-18-005028","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005028/primarydocument.xml","form_type":"4"}},{"id":3727430,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-18T19:48:42.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":116250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in four equal annual installments beginning on December 16, 2019."}],"balance_after":116250,"derivative":{"exercise_price":15.97,"expiration_date":"2028-12-16","underlying":"Common Stock","underlying_shares":116250},"source":{"system":"sec-edgar","filing":"0001562180-18-005028","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005028/primarydocument.xml","form_type":"4"}},{"id":3727429,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2018-12-18T19:48:42.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":19375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs awarded to the reporting person for no additional cash consideration and each represents a contingent right to receive one share of common stock. The RSUs vest and will be settled in common stock in four equal annual installments beginning on December 16, 2019."}],"balance_after":19375,"derivative":{"exercise_price":0,"expiration_date":"2022-12-20","underlying":"Common Stock","underlying_shares":19375},"source":{"system":"sec-edgar","filing":"0001562180-18-005028","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005028/primarydocument.xml","form_type":"4"}},{"id":3727428,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2018-12-18T19:48:42.000Z","date":"2018-12-16","kind":"tax_withholding","acquired":false,"shares":3079,"price":15.97,"value":49171.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations of the reporting person."}],"balance_after":3921,"source":{"system":"sec-edgar","filing":"0001562180-18-005028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005028/primarydocument.xml","form_type":"4"}},{"id":3727427,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2018-12-18T19:48:42.000Z","date":"2018-12-16","kind":"exercise","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued upon settlement of Restricted Stock Units (\"RSUs\") granted on December 27, 2016 and December 16, 2017, as a result of the vesting of one fourth of such RSUs."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001562180-18-005028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005028/primarydocument.xml","form_type":"4"}},{"id":3840473,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-17T17:19:26.000Z","date":"2017-08-15","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning August 15, 2018."}],"balance_after":450000,"derivative":{"exercise_price":8.94,"expiration_date":"2027-08-15","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001562180-18-003685","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003685/primarydocument.xml","form_type":"4"}},{"id":4126847,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-19T21:08:06.000Z","date":"2017-12-16","kind":"grant","acquired":true,"shares":168000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning on December 16, 2018."}],"balance_after":168000,"derivative":{"exercise_price":10.92,"expiration_date":"2027-12-16","underlying":"Common Stock","underlying_shares":168000},"source":{"system":"sec-edgar","filing":"0001562180-17-003959","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003959/primarydocument.xml","form_type":"4"}},{"id":4126846,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":67711,"kind":"person","name":"Oltmans Curtis Gale","position":1,"cik":"0001714982","reported_name":"Oltmans Curtis Gale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2017-12-19T21:08:06.000Z","date":"2017-12-16","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Consists of RSUs awarded to the reporting person for no additional cash consideration each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock. The RSUs vest and will be settled in stock in four equal annual installments beginning on December 16, 2018."}],"balance_after":28000,"derivative":{"exercise_price":0,"expiration_date":"2021-12-17","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001562180-17-003959","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003959/primarydocument.xml","form_type":"4"}}]}